Mutations in aARS genes revealed by targeted next-generation sequencing in patients with mitochondrial diseases

[1]  D. Zee,et al.  Expansion of the clinical spectrum associated with AARS2‐related disorders , 2019, American journal of medical genetics. Part A.

[2]  M. Mirande,et al.  Mutations in KARS cause a severe neurological and neurosensory disease with optic neuropathy , 2019, Human mutation.

[3]  K. Musier-Forsyth.  Aminoacyl-tRNA synthetases and tRNAs in human disease: an introduction to the JBC Reviews thematic series , 2019, The Journal of Biological Chemistry.

[4]  J. Jia,et al.  AARS2 leukoencephalopathy: A new variant of mitochondrial encephalomyopathy , 2019, Molecular genetics & genomic medicine.

[5]  M. Sissler,et al.  When a common biological role does not imply common disease outcomes: Disparate pathology linked to human mitochondrial aminoacyl-tRNA synthetases , 2019, The Journal of Biological Chemistry.

[6]  R. Govindarajan,et al.  Leucoencephalopathy with brain stem and spinal cord involvement and lactate elevation: a novel mutation in the DARS2 gene , 2019, BMJ Case Reports.

[7]  A. Munnich,et al.  Inhibition of mitochondrial translation in fibroblasts from a patient expressing the KARS p.(Pro228Leu) variant and presenting with sensorineural deafness, developmental delay, and lactic acidosis , 2018, Human mutation.

[8]  R. Marconi,et al.  AARS2‐related ovarioleukodystrophy: Clinical and neuroimaging features of three new cases , 2018, Acta neurologica Scandinavica.

[9]  R. Houwen,et al.  Aminoacyl-tRNA synthetase deficiencies in search of common themes , 2018, Genetics in Medicine.

[10]  A. Pichiecchio,et al.  KARS-related diseases: progressive leukoencephalopathy with brainstem and spinal cord calcifications as new phenotype and a review of literature , 2018, Orphanet Journal of Rare Diseases.

[11]  E. Wang,et al.  Mutations in KARS cause early‐onset hearing loss and leukoencephalopathy: Potential pathogenic mechanism , 2017, Human mutation.

[12]  E. Westhof,et al.  Recent Advances in Mitochondrial Aminoacyl-tRNA Synthetases and Disease. , 2017, Trends in molecular medicine.

[13]  O. Poch,et al.  MiSynPat: An integrated knowledge base linking clinical, genetic, and structural data for disease‐causing mutations in human mitochondrial aminoacyl‐tRNA synthetases , 2017, Human mutation.

[14]  E. Bertini,et al.  Novel mutations in KARS cause hypertrophic cardiomyopathy and combined mitochondrial respiratory chain defect , 2017, Clinical genetics.

[15]  Nick C Fox,et al.  Clinical and genetic characterization of leukoencephalopathies in adults , 2017, Brain : a journal of neurology.

[16]  Robert W. Taylor,et al.  Lethal Neonatal LTBL Associated with Biallelic EARS2 Variants: Case Report and Review of the Reported Neuroradiological Features. , 2016, JIMD reports.

[17]  Wong,et al.  Clinical and genetic characterisation of infantile liver failure syndrome type 1, due to recessive mutations in LARS , 2015, Journal of Inherited Metabolic Disease.

[18]  Beril Talim,et al.  Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies. , 2014, JAMA.

[19]  A. Vanderver,et al.  Novel (ovario) leukodystrophy related to AARS2 mutations , 2014, Neurology.

[20]  V. Tiranti,et al.  The Mitochondrial Aminoacyl tRNA Synthetases: Genes and Syndromes , 2014, International journal of cell biology.

[21]  V. Mootha,et al.  Targeted exome sequencing of suspected mitochondrial disorders , 2013, Neurology.

[22]  E. Bertini,et al.  Leukoencephalopathy with thalamus and brainstem involvement and high lactate 'LTBL' caused by EARS2 mutations. , 2012, Brain : a journal of neurology.

[23]  Matej Oresic,et al.  Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. , 2011, American journal of human genetics.

[24]  J Andrew Berglund,et al.  Role of RNA structure in regulating pre-mRNA splicing. , 2010, Trends in biochemical sciences.

[25]  E. Green,et al.  The role of aminoacyl-tRNA synthetases in genetic diseases. , 2008, Annual review of genomics and human genetics.

[26]  A. Ohtake,et al.  Biochemical and molecular diagnosis of mitochondrial respiratory chain disorders. , 2004, Biochimica et biophysica acta.

[27]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[28]  E. Tolkunova,et al.  The Human Lysyl-tRNA Synthetase Gene Encodes Both the Cytoplasmic and Mitochondrial Enzymes by Means of an Unusual Alternative Splicing of the Primary Transcript* , 2000, The Journal of Biological Chemistry.

[29]  H. Lewin,et al.  A simple method for DNA extraction from leukocytes for use in PCR. , 1992, BioTechniques.

[30]  C. Bris,et al.  Next generation sequencing in family with MNGIE syndrome associated to optic atrophy: Novel homozygous POLG mutation in the C-terminal sub-domain leading to mtDNA depletion. , 2019, Clinica chimica acta; international journal of clinical chemistry.

[31]  Ryan L. Davis,et al.  Mitochondrial diseases. , 2018, Handbook of clinical neurology.

[32]  F. Scaglia,et al.  Mitochondrial cytopathies. , 2016, Cell calcium.

[33]  Jianzhu Ma,et al.  RaptorX server: a resource for template-based protein structure modeling. , 2014, Methods in molecular biology.

[34]  N. Guex,et al.  SWISS‐MODEL and the Swiss‐Pdb Viewer: An environment for comparative protein modeling , 1997, Electrophoresis.

[35]  A. Rötig.  [Mitochondrial cytopathies]. , 1996, Pathologie-biologie.